Directory · US
Biotechnology in United States
A register of firms and the professionals working at them in the Biotechnology sector based in United States. Browse the public index, then filter or export on Kipplo.
Companies
2.7K on file
Talecris Biotherapeutics, Inc
We are a biopharmaceutical company that is one of the largest producers and marketers of plasma-derived protein therapies in the world. We develop, produce, market, and distribute therapies that extend and enhance the lives of people suffering from chronic and acute, often life-threatening, conditions, such as chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), alpha-1 antitrypsin deficiency, bleeding disorders, infectious diseases and severe trauma. Our products are derived from human plasma, the liquid component of blood, which is sourced from our plasma collection centers or purchased from third parties, located in the United States.
1001 to 5000 staff
Wheeler Bio, Inc
Wheeler Bio is a pioneering Contract Development and Manufacturing Organization (CDMO) focused on accelerating the discovery-to-development process for biopharmaceutical companies. Through a unique partnering model, we aim to address industry bottlenecks by facilitating smoother transitions between discovery and development phases, empowering innovators to bring novel antibody and antibody-like therapeutics to market with precision, speed, and optimized cost without ever compromising quality. Wheeler Bio specializes in mammalian cell line and process development, GLP Tox material supply, and CGMP clinical supply, leveraging our Portable CMC® platform to streamline the pathway from innovation to clinical trials. Our approach has been purposefully designed to reduce lifecycle challenges, enhance efficiency, and foster lasting collaborations within the biopharma industry.
51 to 200 staff
Abcentra
We are a clinical-stage biopharmaceutical company focused on bringing new and better treatment options to patients with coronary artery disease (CAD), with the aim of preventing heart attacks. Abcentra’s core technology allows for targeting of oxidized low-density lipoprotein (OxLDL), a novel and highly specific approach to quelling coronary inflammation, which has the potential to maximize efficacy and safety compared to other anti-inflammatory therapies for CAD. The Company’s clinical-stage product, Orticumab, is a first-in-class monoclonal antibody against oxidized LDL (OxLDL), the critical driver of atherosclerotic disease and heart attack. Abcentra is developing Orticumab for secondary prevention of cardiac events after an acute coronary syndrome (ACS), with further plans to expand use of orticumab into primary prevention in CAD patients with coronary inflammation.
1 to 10 staff
Acclinate
Our mission is to empower communities to take actions for better health. Acclinate combines cutting-edge technology with grassroots community engagement to connect, educate, and empower underrepresented communities.
51 to 200 staff
Achieve Life Sciences
Achieve Life Sciences is a late-stage specialty pharmaceutical company committed to advancing cytisinicline as a potential treatment of nicotine dependence for smoking cessation.
11 to 50 staff
Adrx, Inc
Preclinical biotechnology company leveraging proprietary structure-based technology to develop small molecule disaggregators and inhibitors targeting previously undruggable misfolded proteins in neurodegenerative diseases. Our pipeline consists of tau, TDP-43 and alpha-synuclein programs.
1 to 10 staff
Airway Therapeutics
Created in 2011 as a spin-out of Cincinnati Children's Hospital Medical Center (CCHMC), Airway Therapeutics has extensive expertise in protein development for applications in the lungs and pediatrics. Airway Therapeutics is in advanced preclinical phase of developing AT-100 (rhSP-D), a product targeting bronchopulmonary dysplasia (BPD) in newborns.
1 to 10 staff
American Gage
American Gage is a leading metrology laboratory in Southern California serving the Life Science & Aerospace industry for over 50 years. We are a distributor for major instrument manufacturers providing third party NIST traceable calibration for both client test equipment and instrument sales. We offer personal and prompt service covering a wide range of capabilities in our environmentally controlled laboratory as well as at customer facilities (on-site service). We gained our Certificate of Accreditation for compliance with ISO/IEC 17025:2005 (which included applicable ISO 9001:2008 requirements) through International Accreditation Service in 2008 and are currently accredited through A2LA to include ISO/IEC 17025:2017, ANSI/NCSL Z540-1-1994, & ANSI/NCSL Z540.3-2006. Our calibration system is designed to comply as required with ANSI/NCSL Z540, ISO 10012 and the former MIL-STD 45662A. Our laboratory is equipped with state of the art equipment and reference standards traceable to the National Institute of Standards and Technology (NIST).
11 to 50 staff
Animal Care Systems
Animal Care Systems was founded in 1997 by a PhD, DVM Neuroscientist, Dr. Germain Rivard. He was a hands-on rodent behavior scientist who concluded that data collected from the animals was skewed by the absence of advanced technology for housing animals. Rudimentary motorized IVC racks were available that delivered fresh air to the rodents and removed waste air but this equipment was loud, emitted ultrasound, put heat loads and allergens into the room and, in addition, vibrated the rodents in their cages. He also noticed that the allergens released into the room from the motorized racks causing an increase in the rate of laboratory animal allergies as well as increasing the presence of waste gases such as ammonia, which can be very repugnant to both people and rodents. He spent years researching animal behavior and evaluating the various caging technologies on the market and concluded that there was no system on the market that was focused on animal and technician welfare. Dr. Rivard proceeded to invent a new style of individually ventilated cage, that would provide an optimal microenvironment for the rodents as well as a better work environment for the people that work with the animals. He invented the first motor-free, ventilated rack system and called it the M.I.C.E. System. M.I.C.E. focusing on 4 fundamental necessities; M: Microenvironmental comfort, I: Isolation, C: Containment E: Enrichment. Dr. Rivard was a pioneer in the field of reduction and elimination of non-experimental variables which is now widely studied and implemented. Animal Care Systems proudly carries on the tradition of our founder and strives to continually innovate and improve the performance of new product lines and services we provide, while remaining focused on animal and personnel welfare.
11 to 50 staff
Aquasyn Llc
Aquasyn diaphragm valves have been in use since 1995 safeguarding many of the most valuable products of the world’s largest Biotechnology firms. Our extensive process engineering and manufacturing experience has enabled us to provide the dynamic biotechnology and pharmaceutical markets with standard, as well as customized, valves and associated components that are highly innovative and of uncompromising quality. Aquasyn has produced a high purity diaphragm valve setting a new standard in engineering, design and manufacturing that is now conceived and executed specifically to meet the needs of the bio-pharmaceutical industry. We are committed to accommodate your ideas like no other high purity valve company can! Services and Products: • 3D Custom design • Project Management • System Engineering Services • Custom Valve Design • Single Use/ Diaphragm Valves • Disposal/ Arterial Valves • Sample/ Bleed Valves • Magnetic Mixer Manufacturing Capabilities: • Fabrication • Assembly • Welding • Mechanical polishing • Electro polishing • Ultrasonic Cleaning • Passivation • & many more! Check out our website to find further information on our products and services at:
11 to 50 staff
Aridis Pharmaceuticals
Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The company’s pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR).
11 to 50 staff
Arpeggio Biosciences
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development. We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
1 to 10 staff
Asc Therapeutics
ASC Therapeutics focuses on the development of curative therapies for rare diseases. Our gene, CRISPR and cell therapies were developed at Applied StemCell, a life sciences company for over 12 years, including proprietary gene editing technologies. Our development pipeline includes several preclinical stage projects focusing on monogenic blood disorders that exhibit a high genetic penetrance and conditions requiring immunomodulatory interventions. Contact us for partnership opportunities.#therapeutics #CRISPR #celltherapy #genetherapy #blooddisorders #hemophilia
51 to 200 staff
Avalo, Inc
AI/ML driven discovery for complex traits & faster, more economical breeding for climate resilient crops
11 to 50 staff
Avellino
Avellino turns genomic analytics into actionable healthcare insights, creating a healthier future for all. Powered by artificial intelligence and machine learning, its genetic discovery engine drives disruptive healthcare innovations. Avellino’s expertise spans a broad spectrum of healthcare specialties, including the impact of genetics in ophthalmology, oncology, pathogenomics and infectious diseases. As a global leader in leveraging artificial intelligence-powered algorithms, Avellino’s diagnostics provide eye care professionals with personalized genetic data to predict eye disease, prevent disease progression and ultimately preserve vision. Avellino has completed more than one million genetic eye tests since 2008, commercialized in the United States, South Korea and Japan. Its world class CLIA-certified laboratory in California has tested more than four million patients for COVID and RSV. Avellino’s research and development team has made groundbreaking discoveries leveraging genetic data, with programs in early detection of oncology, a polygenic risk analysis for glaucoma, and a siRNA gene-silencing therapeutic for the treatment of granular corneal dystrophy type II (currently in preclinical development). With a focus on health equity, Avellino prioritizes the inclusion of ethnically diverse populations in its studies to maximize the impact of its genomics breakthroughs for global healthcare. Avellino is headquartered in Silicon Valley, California, with operations in Korea, Japan, and the UK.
201 to 500 staff
Axcend
Axcend is a provider of innovative, compact capillary liquid chromatography (LC) systems offering dramatic improvements in portability, ease of operation, rapid and convenient deployment, and coupling to other analytical systems (such as mass spectrometry). Axcend's first product — the Axcend Focus LC — emphasizes simplicity and ease of transport, while still retaining high performance and robustness. Developed in the laboratories at Brigham Young University under the direction of Prof. Milton Lee (renowned expert in miniaturized chromatography design and operation), the key features of the Axcend Focus LC include low-power consumption with line voltage or battery operation as standard features; simple and tool-less column exchange via a column cartridge; dramatic reduction in solvent, sample, and waste volume; hand-portable size and weight; novel LED UV-absorption detection for sensitive target analyte detection; and elegant user interface supporting leading computer and mobile devices. The Axcend Focus LC was introduced at the Pittcon 2018 Conference & Exposition where it won a Bronze Pittcon Excellence Award from "Pittcon Today" magazine.
11 to 50 staff
Beeflow
Beeflow creates nature based solutions to help farmers improve the impact of pollination in agriculture by leveraging scientific knowledge and technology. Pollination is critical to crop success as it sets the ceiling for crop yield and quality potential. Inefficient or lack of pollination can reduce crop yields, cause malformation and small-sized crops, contribute to fruit diseases and ultimately increase food waste.
11 to 50 staff
Berkeley Yeast
Berkeley Yeast uses synthetic biology and process engineering to develop products with transformative impact on fermentation, particularly in the beer and wine sectors. With proven traction in these markets, and with support from government grants (NSF, NIH, USDA) and venture capital, we are expanding our research and manufacturing pipelines. Currently available products in the market give unprecedented control over flavors and improve production efficiency. And that’s just the beginning. We are hiring—come join our team to build the future of fermentation. Learn more about our company and products here: Why Genetically Modified Yeast Could Be the Next Step in Beer’s Evolution 6 Beer Industry Trends to Watch in 2022 https://daily.sevenfifty.com/6-beer-industry-trends-to-watch-in-2022/
11 to 50 staff
Biocleaner, Inc
WHO WE ARE? BioCleaner is a high tech US patented technology to treat all kinds of organic waste including residential, commercial, industrial, and municipal sectors. The machine can breakdown unwanted waste leaving no sludge at the fastest rate with the lowest carbon footprint. We have specialized units to treat different bodies of water such as Golf ponds. WHAT WE DO? We do Bioremediation of pond waters using green and biosafety level 1 bacteria. The concept is simply the use of bacteria to reduce Cyanobacteria, odor, color, etc. This is a well-established technology. WHAT ARE THE ADVANTAGES OF OUR SYSTEM? No dredging. No-load system like nutrients, BOD and chemicals Fish and birds will thrive and multiply Flexibility in relocation Low maintenance cost Treats Odor (Geosmin) Treats harmful algal bloom(HAB) Treats Cyanotoxins Encourages Chlorella treats TP as a resource rather than an enemy Our technology continually supplies new bacteria from an established colony, and thus eliminate the constant need to purchase chemicals. HOW IT WORKS: The Biocleaner approach is to supply a permanent bacteria colony on a unique growth media that allows the bacteria to exist essentially in stasis until the bio-augmentation unit is placed into a body of water where both oxygen and food exist. The unit is simple and is submerged in the process pond. A small blower supplies air directly into the media which activates the bacteria. The bacteria begin to replicate with the spawn spreading into the water around the unit. The initial inoculum is trapped on the specialized ceramic media and as such, the unit is never exhausted of its supply. WHAT MAKES US DIFFERENT? Unlike other pond cleaning processes, our system is very simple, requires little attention and generates little sludge and our operating costs are very low. For more info please contact: info@biocleaner.com +1 (323) 981 0797
1 to 10 staff
Biomedical Solutions, Inc
Biomedical Solutions Inc (BSI) is a leading manufacturer’s representative of laboratory equipment based in Stafford, Texas, just outside of Houston. BSI has a highly trained sales and support organization that directly services the Southwest and Southeast, covering 12 states. We also serve the continental United States with our BSI laboratory refrigerators, freezers and freezer racks.
1 to 10 staff
Biostem Technologies Otc Bsem
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.
11 to 50 staff
Bioverativ, A Sanofi Company
Bioverativ, a Sanofi company, is dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development, and commercialization of innovative therapies. We are committed to actively working with the blood disorders community, and our hemophilia therapies when launched represented the first major advancements in hemophilia treatment in more than two decades. For more information, visit or follow @bioverativ on Twitter.
201 to 500 staff
Brammer Bio
Brammer Bio is a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies. Brammer offers end-to-end CDMO services from Phase I/II in Florida through commercial manufacturing in Massachusetts. Brammer Bio provides clinical and commercial supply of viral vectors for in vivo gene and ex vivo modified-cell based therapies, process and analytical development, and regulatory support, enabling large pharma and biotech clients to accelerate the delivery of novel medicines to improve patient health. The Brammer team consists of extraordinary employees focused exclusively on serving the gene therapy needs of clients and their patients. We are Helping to Cure.® The management team is led by President and CEO Mark Bamforth; Chief Scientific Officer Dr. Richard Snyder, the founder of Florida Biologix, which was spun out of the University of Florida in 2015; and Chief Operating Officer Christopher Murphy. Brammer Bio offers a competitive benefits package, including medical, dental, vision, paid time off, holidays, 401(k) with a company match, incentive bonus, flexible spending account (FSA), and educational assistance.
201 to 500 staff
Casss Sharing Science Solutions
is a not-for-profit 501(c)(6) professional scientific society made up of over industry, academic, and regulatory professionals. provides its members a rich array of educational and networking opportunities through our family of symposia. We promote strong peer-to-peer and business relationships. membership includes scientists from more than 80 nations and nearly every continent. Our meetings take place throughout North America, Europe, Asia, and South America. The majority of meetings are small - approximately 125 to 150 attendees - offering a collegial atmosphere with ample opportunity to meet others and truly interact with folks who understand what you do. is dedicated to facilitating the sharing of resources, information, and best practices in order to advance scientific knowledge for the benefit of our members and the public at large. Membership is complimentary and is open to all who support the objectives of and are willing to contribute to the achievement of those objectives. MISSION is an agile, non-profit scientific community whose strength is bringing together professionals from industry, academia, and regulatory agencies to solve scientific and technical problems to advance the field of biopharmaceutical development. VISION Through our dedicated network of volunteers, we create a collaborative culture for various professionals to address scientifically-relevant challenges. provides you with opportunities to connect with a global network to help bring biopharmaceutical medicines to patients quickly, safely, and for less cost. Our members include process, analytical, regulatory, and other related scientists in the field of biopharmaceutical development and regulation.
11 to 50 staff
